Burden of Acute Viral Hepatitis — China, 1990−2019

What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shicheng, Wang, Qiqi, Wang, Shujun, Zhang, Jiaojiao, Hu, Yuehua, Li, Junqi, Long, Xiaojuan, Xiang, Xianglong, Zhou, Maigeng, Tan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428429/
https://www.ncbi.nlm.nih.gov/pubmed/34594713
http://dx.doi.org/10.46234/ccdcw2020.156
Descripción
Sumario:What is already known about this topic? The World Health Organization’s (WHO) Global Health Estimates (GHE) reported that acute hepatitis caused 9,213 deaths and 307,720 person years of disability-adjusted life years (DALYs) in 2016, and acute hepatitis B accounted for 85.81% of all DALYs among acute hepatitis types A, B, C, and E in China. What is added by this report? In China, the percent changes in years lived with disability (YLDs) due to acute hepatitis A, B, and E in groups aged 50–69 years and 70 years or more and in all age groups for acute hepatitis C were increased from 2000 to 2019. What are the implications for public health practices? Effective vaccines, interventions, and treatments are key approaches to achieve the WHO’s goal of reducing new hepatitis infections by 90% and deaths by 65% between 2016 and 2030.

Ejemplares similares